RE:RE:PINKS DOWN .1 RVX up 5Yes you posed the same question before. And the answer is the same since none of the Resverlogix events mentioned in the previous post have happened yet (Yale Club, GCFF, AGM, BETonMACE enrollment launch, orphan disease announcment). Friday 9/25 we have the Yale Club Presentation in New York 12-2:30 p.m. ET
Saturday 9/26 we have the GCFF (Global Chinese Financial Forum) in Toronto with DM giving the keynote speech, slotted for 40 minutes beginning at 9:30 a.m. ET
Wednesday 9/30 we have the AGM in Calgary (9 a.m. MT)
At Rodman and Renshaw on 9/10, regarding the Orphan indication Don said "And of course, very soon, within a matter of a couple weeks, we will be announcing an orphan indication that we will be moving forward with with RVX-208. Our future orphan indications will be with follow-on molecules, however in this first one we have such an advantage time-wise by using 208, that it seems to make a lot of sense to do that." I consider his "couple of weeks" to be 14 days plus or minus a few days. So he has a few more days for holding true to this one. I'd say if Monday rolls by without hearing anything then we have cause to gripe.
At Rodman and Renshaw on 9/10, regarding BETonMACE Don said "We’re actually within a very short few weeks from starting enrollment. So we will announce that when we do. We’re getting very close; it’s getting quite exciting." It hasn't been a few weeks yet (I think of a few as 3 or more).
Read more at https://www.stockhouse.com/companies/bullboard/t.rvx/resverlogix-corp#mZ5Ll7Kv8j8zDU9V.99